The Leading Solution to Manage Patients with Structural Heart Disease
Aortic Stenosis
Mitral Stenosis
Tricuspid Regurgitation
Aortic Regurgitation
Mitral Regurgitation
Aortic Stenosis
Aortic Regurgitation
Mitral Stenosis
Mitral Regurgitation
Tricuspid Regurgitation
Overview
The CardioCare Program
Developing integrated solutions for healthcare that deliver actionable insights for better outcomes. This leading-edge combination of software and services powers insights that close gaps that can cause undertreatment in structural heart disease.
+37%
- IDENTIFIED
- Increase in patients meeting severe Aortic Stenosis (AS) criteria per the AHA/ACC guidelines
+29%
- DIAGNOSED
- Increase in patients diagnosed with severe AS
+35%
- REFERRED
- Increase in patients referred to cardiovascular specialist
+54%
- THERAPY
- Increase in patients receiving a therapy plan
**Analysis represents aggregate median performance across 14 sites with baseline data after six months of using the CardioCare program.
The Solution
Improving Outcomes
This leading-edge solution delivers actionable insights through intuitive digital-health platforms, proprietary A.I. powered analytics and deep clinical expertise to help leading systems elevate the standard of patient care.
Overview
How It Works
The CardioCare program is the industry leader in structural heart data analytics and clinical process improvement, reducing variability in diagnoses and improving guideline-directed treatment by focusing on:
Echo Lab Quality
Ensuring patients receive complete exams for structural heart disease
Diagnostic Precision
Reducing variability in diagnoses for timely and accurate identification of disease
Care Pathway Optimization
Streamlining clinical workflow to elevate the standard of care and ensure patients receive timely treatment
* This product is not intended for use in the diagnosis, cure, mitigation, treatment or prevention of structural heart diseases.
Testimonials
Leading hospitals partner with egnite’s CardioCare program to reduce variability in diagnoses and improve guideline-directed therapy for patients with structural heart disease.

Swedish Medical Center

Director of Structural Interventions, Stanford Health Care

Vice President Northwestern Medical Group Chief, Division of Cardiac Surgery
Resources

PRESS RELEASE: egnite, Inc. Launches as a Digital Health Company
Track record of success builds confidence to close treatment gaps for structural heart disease patients.